Gregory Korbel
Operationeel Directeur bij Atrin Pharmaceuticals, Inc.
Vermogen: 5 741 $ op 30-04-2024
Actieve functies van Gregory Korbel
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Atrin Pharmaceuticals, Inc.
 Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the private company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Operationeel Directeur | - | - |
Loopbaan van Gregory Korbel
Eerdere bekende functies van Gregory Korbel
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| APREA THERAPEUTICS, INC. | Operationeel Directeur | 01-05-2022 | 31-03-2023 |
| Corporate Officer/Principal | 01-07-2016 | 01-05-2022 | |
Novira Therapeutics LLC
 Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Operationeel Directeur | 01-08-2012 | 01-12-2015 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Opleiding van Gregory Korbel
| Vanderbilt University | Undergraduate Degree |
| Harvard University | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Chief Operating Officer | 3 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| APREA THERAPEUTICS, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Novira Therapeutics LLC
Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Health Technology |
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the private company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Health Technology |
- Beurs
- Insiders
- Gregory Korbel
- Ervaring
